Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease

P W Connelly1, G F Maguire, J A Little

  • 1Lipid Research Clinic, St. Michael's Hospital, Toronto, Canada.

Insights

A rare genetic mutation caused a lack of functional apolipoprotein CII (apoCII) in siblings, leading to severe hypertriglyceridemia (chylomicronemia). This apoCII variant, apoCII St. Michael, resulted from a gene defect and was linked to premature vascular disease.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Chylomicronemia is a severe lipid disorder characterized by elevated triglyceride-rich lipoproteins.
  • Apolipoprotein CII (apoCII) is crucial for chylomicron metabolism and triglyceride clearance.

Purpose of the Study:

  • To investigate the molecular basis of chylomicronemia in siblings from a consanguineous mating.
  • To identify and characterize the genetic defect responsible for the absence of functional apoCII.

Main Methods:

  • Two-dimensional electrophoresis and Western blot analysis using anti-apoCII antiserum.
  • Peptide mapping via reverse-phase high-pressure liquid chromatography and amino acid composition analysis.
  • Gene sequencing and deduced protein sequence analysis.

Main Results:

  • A novel mutant apoCII, designated apoCII St. Michael (apoCIIs), was identified with an increased molecular weight.
  • apoCIIs resulted from a frameshift mutation at Gln70, leading to premature termination at Pro96.
  • Both affected siblings were homozygous for apoE-4, suggesting linkage disequilibrium at the apoE-CII gene locus on chromosome 19.

Conclusions:

  • The identified apoCII mutation is causative of chylomicronemia.
  • The apoCII deficiency, in conjunction with apoE-4 homozygosity, may predispose to premature ischemic vascular disease.
  • This case highlights the importance of apoCII in lipid metabolism and cardiovascular health.

Related Concept Videos

RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...